Standout Papers

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, doub... 2020 2026 2022 2024289
  1. Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial (2020)
    Anthony Traboulsee, Benjamin Greenberg et al. The Lancet Neurology

Immediate Impact

65 standout
Sub-graph 1 of 22

Citing Papers

Nanomaterials in Antibacterial Photodynamic Therapy and Antibacterial Sonodynamic Therapy
2024 Standout
The immunostimulatory nature of mRNA lipid nanoparticles
2024 Standout
2 intermediate papers

Works of Yusuke Terada being referenced

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
2020 Standout
Intestinal P-glycoprotein Expression is Multimodally Regulated by Intestinal Ischemia-Reperfusion
2014

Author Peers

Author Last Decade Papers Cites
Yusuke Terada 253 45 65 226 70 15 386
Simona Toscano 217 87 57 136 58 24 390
Amer Awad 278 51 80 125 79 14 419
Giordani Rodrigues dos Passos 259 41 76 164 83 17 363
Prudence N. Gatt 217 42 83 149 105 13 342
Setty M. Magaña 325 33 46 280 103 12 437
R. A. Koopmans 375 53 30 137 112 12 442
Viktoria Papp 290 48 48 165 88 15 389
R. Taiuti 138 18 44 233 53 18 341
Bernd Kitze 153 62 185 129 44 17 398
Jyh Yung Hor 277 14 40 268 106 17 362

All Works

Loading papers...

Rankless by CCL
2026